Tag: clinical trial

Newer clot-busting medication may someday increase time window for stroke treatment

In a phase 2a clinical trial in China, the clot-busting medication tenecteplase has been shown to be effective in restoring blood flow to the...
Diversion-p64 study

Large prospective study demonstrates high efficacy and low mortality rates with...

The Diversion-p64 study—the largest prospective study using the p64 flow modulation device (phenox) to date—has demonstrated that the device has a high level of...
imperative wfitn 2022

Imperative Care enrols first patient in trial evaluating Zoom 88 Large...

Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...
neurovasc envi-sr trial china

NeuroVasc announces enrolment of first patient in ENVI-SR mechanical thrombectomy system...

NeuroVasc Technologies has announced that the first patient has been treated in a pivotal randomised controlled trial (RCT) in China, which will evaluate the...
stroke rehabilitation study

Stroke study reveals optimal timing and intensity for arm and hand...

A phase II, randomised clinical trial has found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should...
fred flow diverter

FRED flow diverter safe and effective in treatment of “appropriately selected”...

The Flow Redirection Endoluminal Device stent system (FRED; MicroVention)—a flow diverter used to treat intracranial aneurysms—has been deemed safe and effective for this indication,...
dbs obesity treatment

Allegheny Health Network initiates clinical trial exploring use of DBS to...

A team of physicians at Allegheny Health Network (AHN) in Pittsburgh, USA has received US Food and Drug Administration (FDA) approval to begin the...

Nevro announces FDA approval of 10kHz high-frequency SCS therapy for painful...

Nevro has announced receipt of US Food and Drug Administration (FDA) approval for its Senza system for the treatment of chronic pain associated with...

Phase 2 clinical trial of NSI-189 in ischaemic stroke initiated

Neuralstem, Inc., a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, has announced the initiation...